Nektar Therapeutics | NKTR - Current Liabilities


Nektar Therapeutics reported $57.71M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agios Pharmaceuticals USD 70.22M 11.37M Jun/2026
ALKERMES USD 662.09M 62.59M Jun/2026
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 25.5B 547M Jun/2026
Baxter International USD 3.59B 102M Jun/2026
BioCryst Pharmaceuticals USD 208.85M 13.46M Jun/2026
Biogen USD 3.92B 918.2M Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Cara Therapeutics USD 11.26M 216K Mar/2026
Cipla INR 70.14B 7.16B Mar/2026
Dr.Reddys Laboratories INR 157.34B 10.13B Jun/2026
Eisai JPY 393.64B 53.39B Jun/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Exelixis USD 361.93M 9.05M Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Grifols EUR 2.37B 156.97M Dec/2025
Halozyme Therapeutics USD 344.44M 18.77M Jun/2026
Incyte USD 1.31B 177.55M Jun/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
Ironwood Pharmaceuticals USD 236.31M 5.91M Mar/2026
Karyopharm Therapeutics USD 117.3M 25.24M Mar/2026
MacroGenics USD 108.82M 12.88M Jun/2026
Merck USD 27.73B 786M Jun/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Neurocrine Biosciences USD 874.5M 42.8M Jun/2026
Novartis USD 31.75B 374M Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sarepta Therapeutics USD 502.91M 3.74M Jun/2026
Takeda JPY 2.76T 335.02B Jun/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026
Xencor USD 81.86M 8.41M Jun/2026